Clinical Trials Browser

Phase 2 × Acrocephalosyndactylia × Rogaratinib × Clear all

Acrocephalosyndactylia

NCT04125693 2022-04-01

Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety

Acrocephalosyndactylia, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)

Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety